Dataset Information

Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.

ABSTRACT: The phosphoinositide 3-kinase (PI3K) inhibitors potently inhibit the signaling pathway of PI3K/AKT/mTOR, which provides a promising new approach for the molecularly targeted cancer therapy. In this work, a novel series of 7-azaindole scaffold derivatives was discovered by the fragment-based growing strategy. The structure-activity relationship profiles identified that the 7-azaindole scaffold derivatives exhibit potent activity against PI3K at molecular and cellular levels as well as cell proliferation in a panel of human tumor cells.

SUBMITTER: Yang C

PROVIDER: S-EPMC5554905 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.

Yang Chengbin C Zhang Xi X Wang Yi Y Yang Yongtai Y Liu Xiaofeng X Deng Mingli M Jia Yu Y Ling Yun Y Meng Ling-Hua LH Zhou Yaming Y

ACS medicinal chemistry letters 20170726 8

The phosphoinositide 3-kinase (PI3K) inhibitors potently inhibit the signaling pathway of PI3K/AKT/mTOR, which provides a promising new approach for the molecularly targeted cancer therapy. In this work, a novel series of 7-azaindole scaffold derivatives was discovered by the fragment-based growing strategy. The structure-activity relationship profiles identified that the 7-azaindole scaffold derivatives exhibit potent activity against PI3K at molecular and cellular levels as well as cell prolif ...[more]

PMID: 28835805

Dataset Information

Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.

Publications

Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors.
| S-EPMC4394348 | biostudies-literature

Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping.
| S-EPMC6427567 | biostudies-literature

Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors.
| S-EPMC7667872 | biostudies-literature

Identification of novel piperazinylquinoxaline derivatives as potent phosphoinositide 3-kinase (PI3K) inhibitors.
| S-EPMC3419191 | biostudies-literature

Discovery of Oxazol-2-amine Derivatives as Potent Novel FLT3 Inhibitors.
| S-EPMC7663913 | biostudies-literature

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3K?.
| S-EPMC5150666 | biostudies-literature

Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.
| S-EPMC4563558 | biostudies-literature

Discovery of Novel, Orally Bioavailable ?-Amino Acid Azaindole Inhibitors of Influenza PB2.
| S-EPMC5304291 | biostudies-literature

Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors.
| S-EPMC7812679 | biostudies-literature

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors.
| S-EPMC6232652 | biostudies-literature